A citation-based method for searching scientific literature

Marilena Melas, Shanmuga Subbiah, Siamak Saadat, Swapnil Rajurkar, Kevin J McDonnell. J Clin Med 2020
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The introduction of hospital networks in Belgium: The path from policy statements to the 2019 legislation.
Melissa De Regge, Kaat De Pourcq, Carine Van de Voorde, Koen Van den Heede, Paul Gemmel, Kristof Eeckloo. Health Policy 2019
4
50

Recommendations to improve the clinical adoption of NGS-based cancer diagnostics in Singapore.
David Shao-Peng Tan, Daniel Shao-Weng Tan, Iain Bee Huat Tan, Benedict Yan, Su Pin Choo, Wee Joo Chng, William Ying Khee Hwang. Asia Pac J Clin Oncol 2020
3
50

Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018.
J Ferlay, M Colombet, I Soerjomataram, T Dyba, G Randi, M Bettio, A Gavin, O Visser, F Bray. Eur J Cancer 2018
785
50

Oncologist Confidence in Genomic Testing and Implications for Using Multimarker Tumor Panel Tests in Practice.
Janet S de Moor, Stacy W Gray, Sandra A Mitchell, Carrie N Klabunde, Andrew N Freedman. JCO Precis Oncol 2020
4
50

Feasibility of next-generation sequencing in clinical practice: results of a pilot study in the Department of Precision Medicine at the University of Campania 'Luigi Vanvitelli'.
Vincenzo De Falco, Luca Poliero, Pietro Paolo Vitello, Davide Ciardiello, Pasquale Vitale, Nicoletta Zanaletti, Emilio Francesco Giunta, Marinella Terminiello, Vincenza Caputo, Francesca Carlino,[...]. ESMO Open 2020
5
50

Roadbook for the implementation of next-generation sequencing in clinical practice in oncology and hemato-oncology in Belgium.
Els Van Valckenborgh, Aline Hébrant, Aline Antoniou, Wannes Van Hoof, Johan Van Bussel, Patrick Pauwels, Roberto Salgado, Waltruda Van Doren, Anouk Waeytens, Marc Van den Bulcke. Arch Public Health 2018
4
50


New Era for Next-Generation Sequencing in Japan.
Masayuki Takeda, Kazuko Sakai, Takayuki Takahama, Kazuya Fukuoka, Kazuhiko Nakagawa, Kazuto Nishio. Cancers (Basel) 2019
13
50

Identification of cancer driver genes based on nucleotide context.
Felix Dietlein, Donate Weghorn, Amaro Taylor-Weiner, André Richters, Brendan Reardon, David Liu, Eric S Lander, Eliezer M Van Allen, Shamil R Sunyaev. Nat Genet 2020
32
50

Artificial intelligence (AI) and big data in cancer and precision oncology.
Zodwa Dlamini, Flavia Zita Francies, Rodney Hull, Rahaba Marima. Comput Struct Biotechnol J 2020
7
50

Standardization of Somatic Variant Classifications in Solid and Haematological Tumours by a Two-Level Approach of Biological and Clinical Classes: An Initiative of the Belgian ComPerMed Expert Panel.
Guy Froyen, Marie Le Mercier, Els Lierman, Karl Vandepoele, Friedel Nollet, Elke Boone, Joni Van der Meulen, Koen Jacobs, Suzan Lambin, Sara Vander Borght,[...]. Cancers (Basel) 2019
7
50

Budget Impact of Next-Generation Sequencing for Molecular Assessment of Advanced Non-Small Cell Lung Cancer.
Tiffany M Yu, Carl Morrison, Edward J Gold, Alison Tradonsky, Renée J G Arnold. Value Health 2018
15
50


Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing.
Grace K Dy, Mary K Nesline, Antonios Papanicolau-Sengos, Paul DePietro, Charles M LeVea, Amy Early, Hongbin Chen, Anne Grand'Maison, Patrick Boland, Marc S Ernstoff,[...]. BMC Med Inform Decis Mak 2019
5
50


Implementing the FAIR Data Principles in precision oncology: review of supporting initiatives.
Charles Vesteghem, Rasmus Froberg Brøndum, Mads Sønderkær, Mia Sommer, Alexander Schmitz, Julie Støve Bødker, Karen Dybkær, Tarec Christoffer El-Galaly, Martin Bøgsted. Brief Bioinform 2020
4
50

Next-Generation Testing for Cancer Risk: Perceptions, Experiences, and Needs Among Early Adopters in Community Healthcare Settings.
Kathleen R Blazer, Bita Nehoray, Ilana Solomon, Mariana Niell-Swiller, Julie O Culver, Gwen C Uman, Jeffrey N Weitzel. Genet Test Mol Biomarkers 2015
33
50

How can we monitor the impact of national health information systems? Results from a scoping review.
Marie Delnord, F Tille, L A Abboud, D Ivankovic, H Van Oyen. Eur J Public Health 2020
5
50

Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States.
Farhad Islami, Ann Goding Sauer, Kimberly D Miller, Rebecca L Siegel, Stacey A Fedewa, Eric J Jacobs, Marjorie L McCullough, Alpa V Patel, Jiemin Ma, Isabelle Soerjomataram,[...]. CA Cancer J Clin 2018
339
50


OncoKB: A Precision Oncology Knowledge Base.
Debyani Chakravarty, Jianjiong Gao, Sarah M Phillips, Ritika Kundra, Hongxin Zhang, Jiaojiao Wang, Julia E Rudolph, Rona Yaeger, Tara Soumerai, Moriah H Nissan,[...]. JCO Precis Oncol 2017
632
50

NGS for (Hemato-) Oncology in Belgium: Evaluation of Laboratory Performance and Feasibility of a National External Quality Assessment Program.
Thomas Delcourt, Kevin Vanneste, Mohamed Rida Soumali, Wim Coucke, Vanessa Ghislain, Aline Hebrant, Els Van Valckenborgh, Sigrid C J De Keersmaecker, Nancy H Roosens, Philippe Van De Walle,[...]. Cancers (Basel) 2020
2
50

Variant classification in precision oncology.
Jonas Leichsenring, Peter Horak, Simon Kreutzfeldt, Christoph Heining, Petros Christopoulos, Anna-Lena Volckmar, Olaf Neumann, Martina Kirchner, Carolin Ploeger, Jan Budczies,[...]. Int J Cancer 2019
21
50

A Canadian guideline on the use of next-generation sequencing in oncology.
S Yip, A Christofides, S Banerji, M R Downes, I Izevbaye, B Lo, A MacMillan, J McCuaig, T Stockley, G M Yousef,[...]. Curr Oncol 2019
15
50

Next-Generation Sequencing and the Clinical Oncology Workflow: Data Challenges, Proposed Solutions, and a Call to Action.
Jake R Conway, Jeremy L Warner, Wendy S Rubinstein, Robert S Miller. JCO Precis Oncol 2019
8
50


Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.
Marilyn M Li, Michael Datto, Eric J Duncavage, Shashikant Kulkarni, Neal I Lindeman, Somak Roy, Apostolia M Tsimberidou, Cindy L Vnencak-Jones, Daynna J Wolff, Anas Younes,[...]. J Mol Diagn 2017
520
50

Personal Genomic Testing for Cancer Risk: Results From the Impact of Personal Genomics Study.
Stacy W Gray, Sarah E Gollust, Deanna Alexis Carere, Clara A Chen, Angel Cronin, Sarah S Kalia, Huma Q Rana, Mack T Ruffin, Catharine Wang, J Scott Roberts,[...]. J Clin Oncol 2017
20
50

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.
Paul A Harris, Robert Taylor, Robert Thielke, Jonathon Payne, Nathaniel Gonzalez, Jose G Conde. J Biomed Inform 2009
50

Barriers to recruitment of rural patients in cancer clinical trials.
Shamsuddin Virani, Lola Burke, Scot C Remick, Jame Abraham. J Oncol Pract 2011
39
50

Use of HER2-Directed Therapy in Metastatic Breast Cancer and How Community Physicians Collaborate to Improve Care.
Joanne E Mortimer, Laura Kruper, Mary Cianfrocca, Sayeh Lavasani, Sariah Liu, Niki Tank-Patel, Mina Sedrak, Wade Smith, Daphne Stewart, James Waisman,[...]. J Clin Med 2020
2
50

The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.
Joseph M Unger, Elise Cook, Eric Tai, Archie Bleyer. Am Soc Clin Oncol Educ Book 2016
174
50

Precision Oncology: Who, How, What, When, and When Not?
Lee Schwartzberg, Edward S Kim, David Liu, Deborah Schrag. Am Soc Clin Oncol Educ Book 2017
42
50

Characterizing the relationships between tertiary and community cancer providers: Results from a survey of medical oncologists in Southern California.
Nicholas J Salgia, Alexander Chehrazi-Raffle, JoAnn Hsu, Zeynep Zengin, Sabrina Salgia, Neal S Chawla, Luis Meza, Jasnoor Malhotra, Nazli Dizman, Ramya Muddasani,[...]. Cancer Med 2021
1
100

Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care.
Sunil Kripalani, Frank LeFevre, Christopher O Phillips, Mark V Williams, Preetha Basaviah, David W Baker. JAMA 2007
50


Association of National Cancer Institute-Sponsored Clinical Trial Network Group Studies With Guideline Care and New Drug Indications.
Joseph M Unger, Van T Nghiem, Dawn L Hershman, Riha Vaidya, Michael LeBlanc, Charles D Blanke. JAMA Netw Open 2019
9
50

Conversations About Financial Issues in Routine Oncology Practices: A Multicenter Study.
Rahma Warsame, Cassie C Kennedy, Ashok Kumbamu, Megan Branda, Cara Fernandez, Brittany Kimball, Aaron L Leppin, Thomas O'Byrne, Aminah Jatoi, Heinz-Josef Lenz,[...]. J Oncol Pract 2019
18
50

NCI-Clinical Trial Accrual in a Community Network Affiliated with a Designated Cancer Center.
Daniel J Kim, Dan Otap, Nora Ruel, Naveen Gupta, Naveed Khan, Tanya Dorff. J Clin Med 2020
2
50

Impact of care at comprehensive cancer centers on outcome: Results from a population-based study.
Julie A Wolfson, Can-Lan Sun, Laura P Wyatt, Arti Hurria, Smita Bhatia. Cancer 2015
70
50

Integrating Academic and Community Practices in the Management of Colorectal Cancer: The City of Hope Model.
Misagh Karimi, Chongkai Wang, Bahareh Bahadini, George Hajjar, Marwan Fakih. J Clin Med 2020
2
50

Implementing Lung Cancer Screening and Prevention in Academic Centers, Affiliated Network Offices and Collaborating Care Sites.
Cary A Presant, Ravi Salgia, Prakash Kulkarni, Brian L Tiep, Shamel Sanani, Benjamin Leach, Kimlin Ashing, Jossie Sandoval, Mina S Sedrak, Shana Landau,[...]. J Clin Med 2020
1
100

Integrating Academic and Community Cancer Care and Research through Multidisciplinary Oncology Pathways for Value-Based Care: A Review and the City of Hope Experience.
Linda D Bosserman, Mary Cianfrocca, Bertram Yuh, Christina Yeon, Helen Chen, Stephen Sentovich, Amy Polverini, Finly Zachariah, Debbie Deaville, Ashley B Lee,[...]. J Clin Med 2021
1
100

How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials.
Warren B Sateren, Edward L Trimble, Jeffrey Abrams, Otis Brawley, Nancy Breen, Leslie Ford, Mary McCabe, Richard Kaplan, Malcolm Smith, Richard Ungerleider,[...]. J Clin Oncol 2002
378
50

A Comprehensive Program for the Enhancement of Accrual to Clinical Trials.
Mark Porter, Bhuvaneswari Ramaswamy, Karen Beisler, Poonam Neki, Nancy Single, James Thomas, Janie Hofacker, Michael Caligiuri, William E Carson. Ann Surg Oncol 2016
7
50

Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect".
D A Braunholtz, S J Edwards, R J Lilford. J Clin Epidemiol 2001
358
50

Advancing the Science and Management of Renal Cell Carcinoma: Bridging the Divide between Academic and Community Practices.
Nicholas J Salgia, Errol J Philip, Mohammadbagher Ziari, Kelly Yap, Sumanta Kumar Pal. J Clin Med 2020
3
50

Analysing potential harm in Australian general practice: an incident-monitoring study.
A L Bhasale, G C Miller, S E Reid, H C Britt. Med J Aust 1998
138
50

Clinical trial accrual among new cancer patients at a community-based cancer center.
Ronald S Go, Kathleen A Frisby, Jennifer A Lee, Michelle A Mathiason, Christine M Meyer, Jodi L Ostern, Sara M Walther, Jonean E Schroeder, Lori A Meyer, Kathryn E Umberger. Cancer 2006
84
50

Survival After Cancer Treatment at Top-Ranked US Cancer Hospitals vs Affiliates of Top-Ranked Cancer Hospitals.
Daniel J Boffa, Katherine Mallin, Jeph Herrin, Benjamin Resio, Michelle C Salazar, Bryan Palis, Matthew Facktor, Ryan McCabe, Heidi Nelson, Lawrence N Shulman. JAMA Netw Open 2020
3
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.